Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.

Pharmaceutical

Acumen Pharmaceuticals

Acumen Pharmaceuticals' headquarters in Charlottesville, VA, United States

Eric Siemers

Russell Barton

Julie Bockenstette

Matthew Zuga

Derek Meisner

Robyn Moxon

Hao Zhang

Jerry Moore

Kathleen Marcozzi Pierce

Kasey Spencer

Alex Braun

Steve Reynolds

Janice Hitchcock

Katie Rink

Steven DeKosky

Grant Krafft

Colin Masters

Michael Weiner

Cynthia Lemere

Laura Stoppel

Reisa Sperling

William Klein

Jeffrey Cummings

Stephen Salloway

Jeffrey L. Ives

Sean Stalfort

Kim Drapkin

Lennart Mucke

Derrell D. Porter

Nathan B. Fountain

The Research and Development team at Acumen Pharmaceuticals is dedicated to the discovery and optimization of innovative therapies targeting amyloid-beta oligomers for Alzheimer's and other neurodegenerative diseases. Comprising a diverse group of scientific and clinical experts, the team conducts in-depth research, develops drug formulations, and manages clinical trials to bring safe and effective treatments from the lab to patients. Their collaborative efforts focus on advancing our understanding of disease biology while ensuring rigorous development processes that align with regulatory standards.

Research and Development

The Clinical Operations Team at Acumen Pharmaceuticals is responsible for overseeing and managing clinical trials focused on the development of treatments for Alzheimer's disease. This team ensures that studies are conducted effectively and in compliance with regulatory standards, collaborates on bioanalytical method validation, and maintains high-quality documentation and control processes to support successful trial outcomes. Their efforts are critical in advancing the company’s mission to provide safe and effective therapies for neurodegenerative diseases.

Clinical Operations Team

The Leadership Team at Acumen Pharmaceuticals is responsible for setting the strategic direction and vision of the company, overseeing the development of innovative treatments for Alzheimer’s and neurodegenerative diseases. This team collaborates to ensure regulatory compliance, drives clinical development, and manages operational efficiencies while fostering a culture of research excellence and patient-focused solutions.

Leadership Team

The Medical and Legal Affairs team at Acumen Pharmaceuticals plays a critical role in ensuring that the company’s research and development efforts align with regulatory standards and legal requirements. This team collaborates on clinical communications, oversees compliance in medical practices, and provides strategic guidance on clinical and operational matters, all while supporting the overall mission to advance innovative treatments for Alzheimer’s disease and other neurodegenerative disorders.

Medical and Legal Affairs

The Finance and Accounting team at Acumen Pharmaceuticals is responsible for managing the company's financial resources and ensuring compliance with regulatory standards. This team handles budgeting, financial reporting, and analysis, enabling effective decision-making that supports the company's mission to develop innovative treatments for Alzheimer's and other neurodegenerative diseases. Their expertise ensures the financial health of the organization, facilitating strategic investments in research and development.

Finance and Accounting

Acumen Pharmaceuticals

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations Team

Leadership Team

Medical and Legal Affairs

Finance and Accounting

Offices

Acumen Pharmaceuticals

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations Team

Leadership Team

Medical and Legal Affairs

Finance and Accounting

Offices

Related companies